HPTC Versus AFSM in Diabetic Foot Ulcers
This clinical trial focuses on diabetic foot ulcers (DFUs), a common and serious complication of diabetes that can lead to amputation if not treated effectively. The study is comparing two advanced wound-healing approaches: a high-purity type-I collagen-based skin substitute and an acellular intact fish skin matrix, both used alongside standard wound care. The trial is currently recruiting participants and will take place at multiple centers in Dhaka, Bangladesh, and in Mandya and Mysore, India. The goal is to see which treatment leads to better healing outcomes for patients. This research matters because DFUs are notoriously difficult to treat, and new options are urgently needed to prevent amputations and improve quality of life. In China, where DFU rates are rising due to increasing diabetes prevalence, specialists are also exploring advanced biologics and skin substitutes, making this trial relevant to global treatment trends.
Key takeaways
- The trial compares two promising skin substitutes—collagen-based and fish skin matrix—both combined with standard care, to see which heals diabetic foot ulcers better.
- Patients with DFUs that haven't responded to standard treatments may benefit from these advanced therapies, which aim to speed healing and reduce amputation risk.
- The study is being conducted in Bangladesh and India, so patients in those regions have direct access; international patients would need to travel to participate.
- This research adds to the growing global effort to find effective, accessible treatments for diabetic foot ulcers, including in China where similar approaches are being studied.
- Ask your doctor if you might be a candidate for clinical trials, and whether collagen or fish skin substitutes are available or appropriate for your wound.
Read the full paper / source →
This content summarizes published medical research for educational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making treatment decisions.
Free consultation
Could this treatment help you?
Our DFU specialists review every inquiry personally. Tell us about your situation — response within 48 hours, no commitment required.
This website provides medical-information science popularization only. It does NOT provide online diagnosis, prescriptions, or medical advice. Consult a licensed physician for any medical decision.
Editor's note
This trial is testing skin substitutes that act like a scaffold to help your body rebuild healthy tissue over the wound—something standard dressings alone often can't do. If your ulcer hasn't healed with regular care or you've been told amputation might be necessary, these approaches aim to give your body a second chance by providing the missing building blocks for repair. In China, some specialist DFU centers already use collagen-based and other biologic skin substitutes, but access varies; if you're considering overseas treatment, know that this trial is in South Asia and may not be available in China yet. Always discuss clinical trial options with your doctor to see if they fit your situation.